Eyepoint Pharmaceuticals (EYPT) has a market capitalization of $437.8M, based on 68.73M shares at a price of $6.37 (down 1.2% yesterday).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
April 2025 | $6.37 | 16,437,363 | 68,728,801 | $437,802,462.37 |
March 2025 | $5.42 | 16,292,291 | 56,298,000 | $305,135,160.00 |
February 2025 | $6.27 | 18,838,854 | 56,298,000 | $352,988,460.00 |
January 2025 | $7.65 | 14,246,323 | 56,298,000 | $430,679,700.00 |
December 2024 | $7.45 | 19,059,815 | 56,298,000 | $419,420,100.00 |
November 2024 | $8.85 | 17,645,400 | 56,298,000 | $498,237,300.00 |
October 2024 | $11.76 | 22,023,153 | 56,298,000 | $662,064,480.00 |
September 2024 | $7.99 | 12,362,216 | 54,449,000 | $435,047,510.00 |
August 2024 | $8.95 | 13,382,305 | 54,449,000 | $487,318,550.00 |
July 2024 | $9.88 | 17,059,479 | 54,449,000 | $537,956,120.00 |
June 2024 | $8.70 | 18,862,367 | 53,206,000 | $462,892,200.00 |
May 2024 | $10.71 | 33,444,309 | 53,206,000 | $569,836,260.00 |
April 2024 | $17.60 | 20,224,503 | 53,206,000 | $936,425,600.00 |
March 2024 | $20.67 | 19,347,965 | 52,913,000 | $1,093,711,710.00 |
February 2024 | $27.21 | 21,608,600 | 52,913,000 | $1,439,762,730.00 |
January 2024 | $26.93 | 21,691,094 | 52,913,000 | $1,424,947,090.00 |
December 2023 | $23.11 | 62,523,037 | 42,168,000 | $974,502,480.00 |
November 2023 | $6.25 | 12,847,049 | 42,168,000 | $263,550,000.00 |
October 2023 | $6.02 | 9,362,169 | 42,168,000 | $253,851,360.00 |
September 2023 | $7.99 | 9,885,440 | 38,341,000 | $306,344,590.00 |
August 2023 | $9.91 | 15,371,097 | 38,341,000 | $379,959,310.00 |
July 2023 | $12.50 | 12,911,914 | 38,341,000 | $479,262,500.00 |
June 2023 | $8.70 | 9,379,154 | 37,576,000 | $326,911,200.00 |
May 2023 | $6.05 | 10,305,865 | 37,576,000 | $227,334,800.00 |
April 2023 | $6.28 | 38,406,702 | 37,576,000 | $235,977,280.00 |
